StockVS

Chiron Real Estate Inc. (XRN) 股票分析

房地产

Chiron Real Estate Inc.

$36.87

$-0.55 (-1.47%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Chiron Real Estate Inc. operates as a net-lease medical real estate investment trust that acquires healthcare facilities to lease them to physician groups and regional or national healthcare systems. The company functions within the Real Estate sector, specifically categorized under the REIT - Healthcare Facilities industry, which denotes its specialization in income-generating properties serving the medical sector. As of the latest data, the organization employs approximately 30 individuals and maintains a total market capitalization of $937.02 million. The company reported annual revenue of $148.06 million over the trailing twelve months, positioning it as a mid-sized player in the specialized medical real estate market. These financial metrics indicate that the company has established a significant asset base, yet the market cap suggests a valuation that requires careful analysis relative to its revenue generation capabilities and operational scale within the competitive healthcare real estate landscape.

财务健康

Chiron Real Estate Inc. reported trailing twelve-month revenue of $148.06 million, accompanied by a net income loss of $12,116,000 and an EBITDA of $91.58 million. The substantial gap between positive revenue and negative net income reveals a cost structure where operating expenses, interest costs, or depreciation significantly erode bottom-line profitability despite strong top-line performance. The entity generated free cash flow of $66.62 million, indicating a robust ability to generate liquidity from operations, which provides essential financial flexibility for debt servicing, capital expenditures, or potential strategic acquisitions. The company exhibits a gross margin of 100.0%, reflecting the net-lease model where leasing costs are often excluded from gross calculations, while an operating margin of 25.1% demonstrates efficient management of operational expenditures relative to revenue. However, the profit margin stands at -3.9%, confirming that non-operating expenses such as interest or taxes are driving the overall loss. On the balance sheet, total cash holdings of $15.19 million are dwarfed by total debt of $667.29 million, resulting in a debt-to-equity ratio of 125.89, which characterizes a highly leveraged capital structure rather than a conservative one. The current ratio of 1.75 suggests adequate short-term liquidity to cover immediate obligations, though the high leverage remains a primary risk factor. Return on Equity is recorded at -1.3%, indicating that shareholder equity is currently being diluted by losses, while Return on Assets sits at 1.9%, showing that the company's asset base generates a small positive return before financing costs are fully accounted for.

估值评估

The trailing P/E ratio is listed as N/A due to negative net income, whereas the forward P/E is -56.88, implying that market expectations for future earnings recovery are not yet priced in a manner that supports a positive multiple. The price-to-book ratio is 1.18, suggesting that the market values the company's equity at a slight premium over its book value, which is notable given the negative earnings environment. Alternative valuation metrics include a price-to-sales ratio of 6.33 and an EV/EBITDA of 13.67; these figures suggest that investors are valuing the firm primarily on its revenue generation and EBITDA potential rather than current profitability. The stock has traded between a 52-week low of $29.05 and a 52-week high of $39.93, with the current price level situated within this historical range, reflecting volatility without extreme detachment from recent trading bands. The beta coefficient of 1.20 indicates that the stock price exhibits volatility that is 20% higher than the broader market, signaling higher sensitivity to market fluctuations. This elevated beta, combined with the high debt load, contributes to a risk profile that is distinct from lower-beta real estate peers.

Growth & Income

Revenue growth year-over-year is 9.2%, while earnings growth is N/A due to the current period losses, indicating that top-line expansion is occurring without immediate translation to bottom-line gains. As a dividend-paying entity, Chiron Real Estate Inc. offers a dividend yield of 8.7%, yet the payout ratio is 1114.3%, which is mathematically unsustainable given the negative net income and suggests that dividends are likely being funded by free cash flow or debt rather than retained earnings. The discrepancy between the high dividend yield and the excessive payout ratio highlights a potential reliance on cash reserves or refinancing to maintain current dividend levels, rather than organic earnings support. Overall, the growth and income profile presents a dual narrative of expanding revenue streams paired with a precarious dividend sustainability linked to a highly leveraged balance sheet and lack of current profitability.

同行比较

Chiron Real Estate Inc. (XRN) 在REIT - 医疗设施行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Chiron Real Estate Inc. XRN $530.22M N/A
Welltower Inc. WELL $153.98B 105.4
Ventas, Inc. VTR $42.96B 160.7
Omega Healthcare Investors, Inc. OHI $15.07B 23.4

REIT - 医疗设施行业平均市盈率为60.2倍。Chiron Real Estate Inc.的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Chiron Real Estate Inc.

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Chiron Real Estate Inc. was established on March 18, 2011, incorporated in Maryland and is based in Bethesda, United States.

公司简介以英文显示。

访问官网 →

关键指标

市值
$530.22M
市盈率
N/A
52周最高
$39.93
52周最低
$29.05
平均成交量
156.86K
Beta系数
1.14
股息率
15.54%

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NYSE
国家
United States
员工数
30